3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Pulmonary Embolism
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Cyclophosphamide
71
fludarabine phosphate
63
Busulfan
47
Peripheral Blood Stem Cell Transplantation
44
Tacrolimus
41
Mycophenolic Acid
37
Antilymphocyte Serum
37
Filgrastim
32
Cyclosporine
30
Melphalan
29
Whole-Body Irradiation
28
Radiotherapy
28
fludarabine
26
Methotrexate
23
Methylprednisolone
18
Etoposide
18
Cord Blood Stem Cell Transplantation
17
Rituximab
13
Alemtuzumab
13
Stem Cell Transplantation
12
Granulocyte Colony-Stimulating Factor
10
Sirolimus
9
Thiotepa
8
Cytarabine
8
sargramostim
7
Prednisone
7
Epoetin Alfa
7
Flow Cytometry
6
thymoglobulin
5
Trimethoprim, Sulfamethoxazole Drug Combination
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
enoxaparin sodium
×
Plasma cell
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled